GlassScriptPhysician profile
Willy Pezzia
NPI 1982604575
$1,871.99
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.67 · 2020: $723 · 2021: $1,083.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $267.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $231.69 | 2020-2021 | |
| Allergan, INC. | $220.74 | 2019-2020 | |
| Pfizer INC. | $181.82 | 2019-2021 | |
| Lilly USA, LLC | $137.33 | 2020-2021 | |
| Glaxosmithkline, LLC. | $110.46 | 2020-2021 | |
| Amarin Pharma, INC. | $102.65 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $94.06 | 2021 | |
| Amgen INC. | $85.64 | 2020-2021 | |
| Novo Nordisk INC | $76.20 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.31 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.09 | 2020-2021 | |
| Horizon Therapeutics Plc | $51.48 | 2021 | |
| Eisai INC. | $36.95 | 2021 | |
| Merck Sharp & Dohme LLC | $28.12 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $26.92 | 2019-2020 | |
| Genentech USA, INC. | $21.67 | 2020 | |
| Paratek Pharmaceuticals, INC. | $20.48 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $17.59 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.35 | 2021 | |
| Medtronic, INC. | $15.03 | 2021 | |
| Mylan Specialty L.P. | $14.30 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willy Pezzia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.